Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000
An accurate and reproducible next-generation sequencing platform is essential to identify malignancy-related abnormal DNA methylation changes and translate them into clinical applications including cancer dete...